Peng Leong, PhD, MBA
Chief Business Officer
BioAge Labs
Peng is Chief Business Officer and Head of Brain Aging at BioAge. He has extensive experience in execution of strategic partnerships, asset in-licensing, and financing transactions. Previously, Peng was CBO of Kazia Therapeutics, responsible for strategy and business development, and in-licensed paxalisib currently in Phase III trials for glioblastoma. Across various roles, including at Merck KGaA and DRI Healthcare, Peng has had a leadership role in the acquisition or sale of over US$ 1 billion in pharmaceutical product rights. He started his career in healthcare investment banking at CIBC World Markets and Piper Jaffray, where he was involved in raising more than US$ 1.4 billion for over 20 biotechnology companies. Peng received a PhD in Biochemistry from the University of Toronto and an MBA from University of California, Berkeley.
Sessions
-
23-Jun-202632ABBeyond GLP-1s – New Mechanisms and Modalities for Metabolic Disease
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}